Belay Diagnostics
Brett Domagala is a seasoned Molecular Technologist with extensive experience in laboratory settings, currently employed at Belay Diagnostics since May 2024. Previous roles include Molecular Technologist positions at Tempus AI and Caris Life Sciences, where responsibilities included complex testing, staff oversight, and protocol updates. Brett has a strong background in maintaining laboratory quality control, training new personnel, and ensuring proper lab procedures. Prior to these roles, Brett held positions at Theranostix Inc., Sonora Quest Laboratories, Cyrex Laboratories, and Food Safety Net Services, gaining diverse expertise from medical technology to microbiology. Brett's academic credentials include a Master of Science in Biological Data Science from Arizona State University, a Master of Science in Microbiology and Cell Science from the University of Florida Online, and a Bachelor of Science in Forensic Science and Technology from Grand Canyon University.
This person is not in any teams
This person is not in any offices
Belay Diagnostics
1 followers
Belay Diagnostics provides next-gen sequencing to detect aneuploidy and mutations with our cerebrospinal fluid testing platform. Improving diagnosis for brain and spinal cord cancers can give people the best chance for a cure without the need for invasive biopsies. We see our technological advances in cerebrospinal fluid assays as offering clinicians alternative diagnostic tools for use in treatment decisions.